Abstract
Purpose of Review
The current literature available to providers on urgency urinary incontinence in orthotopic neobladder patients will be reviewed.
Recent Findings
In this review, we will examine the most recent studies evaluating potential therapies for urgency urinary incontinence in neobladder patients.
Summary
Urgency urinary incontinence in patients with neobladders is a challenging symptom to manage for both patients and providers, both due to the pathophysiology as well as a lack of data on effective therapies. Given the similar symptom profile to patients with overactive bladder as well as comparable functional derangement to irritable bowel syndrome, we explore the potential use of traditional overactive bladder and irritable bowel syndrome therapies in this patient population. Further study is needed in the diagnostic workup and management in urgency neobladder urinary incontinence.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
American Cancer Society. Cancer Facts & Figures 2023. Atlanta, Ga: American Cancer Society; 2022. In: Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD
Daneshmand S, Bartsch G. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther. 2011;11(6):941–8.
Philip J, Manikandan R, Venugopal S, et al. Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy–a quality-of-life based comparison. Ann R Coll Surg Engl. 2009;91(7):565–9.
Large MC, Malik R, Cohn JA, Richards KA, Ganshert C, Kunnavakkum R, Smith ND, Steinberg GD. Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion. Urology. 2014;84(4):808–13.
Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol. 2006;24(3):305–14.
Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol. 2000;18(5):330–7.
O’Connor RC, Kuznetsov DD, Patel RV, Galocy RM, Steinberg GD, Bales GT. Artificial urinary sphincter placement in men after cystectomy with orthotopic ileal neobladder: continence, complications, and quality of life. Urology. 2002;59(4):542–5.
LeDuc A, Camey M, Teillac P. An original antireflux ureteroileal implantation technique: long term follow up. J Urol. 1987;137:1156–8.
Camey M. Bladder replacement by ileocystoplasty following radical cystectomy. Semin Urol. 1987;5(1):8–14.
Sood R, Sharma GP, Gupta NP. The ileal neobladder–an ideal bladder substitute? Med J Armed Forces India. 1996;52(2):67–70.
Lee KS, Montie JE, Dunn RL, Lee CT. Hautmann and Studer orthotopic neobladders: a contemporary experience. J Urol. 2003;169(6):2188–91.
Kim KH, Yoon HS, Song W, Choo HJ, Yoon H, Chung WS, Sim BS, Lee DH. Cluster analysis identifies three urodynamic patterns in patients with orthotopic neobladder reconstruction. PLoS ONE. 2017;12(10): e0185255.
Obara W, Isurugi K, Kudo D, Takata R, Kato K, Kanehira M, Iwasaki K, Tanji S, Konda R, Fujioka T. Eight year experience with Studer ileal neobladder. Jpn J Clin Oncol. 2006;36(7):418–24.
Burgio KL, Goode PS, Locher JL, Umlauf MG, Roth DL, Richter HE, Varner RE, Lloyd LK. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA. 2002;288(18):2293–9.
Hashim H, Al MR. Management of fluid intake in patients with overactive bladder. Curr Urol Rep. 2009;10(6):428–33.
Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. 2012;1:CD005429.
Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006;98(3):503–7.
• El-Bahnasawy MS, Shaaban H, Gomha MA, Nabeeh A. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol. 2008;42(4):344–51. Retrospective study evaluating the efficacy of oxybutynin/verapamil in the management of neobladder incontinence.
• Zahran MH, Harraz AM, Taha DE, Nabeih H, El Hefnawy AS, Ali-El-Dein B. The short-term effects of tolterodine on nocturnal incontinence after orthotopic ileal neobladder: a randomized crossover placebo-controlled study. BJU Int. 2019. Retrospective study evaluating the efficacy of tolterodine in neobladder incontinence.
Fowler JE Jr, Clayton M, Mouli K, Reagan G. Effect of liquid diphenoxylate hydrochloride and atropine sulfate (lomotil) instillations on dynamics and function of continent cecal urinary reservoirs. J Urol. 1987;138(4):735–8.
• Hashem A, Abol-Enein H, Laymon M, Abdellutif MM, Ramez M, Taha MT, El-Hefnawy AS, Mosbah A. A randomized trial to examine the utility of mebeverine on the early return of continence following orthotopic bladder substitution. J Urol. 2021;205(5):1400–1406. Randomized trial assessing the utility of mebeverine in incontinent males less than 1 year following neobladder surgery.
Devinder Singh Bansi, John Louis-Auguste. Clinical Pharmacology (Eleventh Edition), Churchill Livingstone, Chapter 33 – Intestines. 2012, Pages 536–545
• Hashem A, Abdellutif MM, Laymon M, Abdullateef M, Abdelhamid A, Mosbah A, Abol-Enein H. Clinical efficacy of mebeverine for persistent nocturnal enuresis after orthotopic W-neobladder. BJU Int. 2022;129(3):387–393. Retrospective study evaluating the efficacy of mebeverine in nocturnal incontinence in neobladder patients.
Daniluk J, Malecka-Wojciesko E, Skrzydlo-Radomanska B, Rydzewska G. The efficacy of mebeverine in the treatment of irritable bowel syndrome-a systematic review. J Clin Med. 2022;11(4):1044.
Orasanu B, Mahajan ST. The use of botulinum toxin for the treatment of overactive bladder syndrome. Indian J Urol. 2013;29(1):2–11.
• Hoag N, Tse V, Wang A, Chung E, Gani J. Intravesical onabotulinumtoxinA injection for overactive orthotopic ileal neobladder: feasibility and efficacy. Int Neurourol J. 2016;20(1):81–5. Case reports evaluating efficacy of intravesical onabotulinumtoxinA for OAB in orthotopic neobladder patients.
Toia B, Pakzad MH, Hamid R, Wood DN, Greenwell TJ, Ockrim JL. The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: cohort series and literature review. Neurourol Urodynam. 2020;39(6):1831–6.
Martinez L, Tubre R, Roberts R, Boone T, Griebling TL, Padmanabhan P, Khavari R. Refractory bladder dysfunction: a multi-institutional experience with intravesical botulinum toxin-a injection in adult patients who underwent previous augmentation cystoplasty. Turk J Urol. 2020;46(4):309–13.
Miyake H, Hara S, Eto H, Arakawa S, Kamidono S, Hara I. Significance of renal function in changes in acid-base metabolism after orthotopic bladder replacement: colon neobladder compared with ileal neobladder. Int J Urol. 2004;11:83–7.
Funding
No funding was received for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all the applicable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gaines, T., Cohn, J.A. Management of Urgency Urinary Incontinence After Orthotopic Neobladder. Curr Bladder Dysfunct Rep 18, 304–309 (2023). https://doi.org/10.1007/s11884-023-00723-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-023-00723-5